The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The treatment continuum of panitumumab, cetuximab, and bevacizumab in 1st through 3rd line by KRAS, NRAS, and BRAF mutation status among mCRC patients treated at community cancer centers in the United States.
 
Kimberly Lowe
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kristina Hool
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
George Kafatos
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Michael Anthony Kelsh
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Tamer Garawin
Employment - Amgen
Stock and Other Ownership Interests - Amgen